Table 1 Age group characteristics of study subjects.
Controls (20–40) | 40–50 | 50–60 | 60–70 | >70 | |
|---|---|---|---|---|---|
Total number | N = 30 | N = 24 | N = 29 | N = 40 | N = 34 |
Age (mean ± SD) | 25.3 (4.2) | 45.2 (2.6) | 55.1 (2.6) | 65.8 (2.5) | 76.9 (5.5) |
Range | 20–40 | 40–49 | 51–59 | 61–69 | 70–95 |
Males (n; %) | 11 (36.7%) | 10 (41.7%) | 11 (37.9%) | 14 (35%) | 12 (40%) |
CMV− (n; %) | 6 (54.5%) | 8 (80%) | 7 (63.6%) | 7 (50.0%) | 4 (33.3%) |
CMV+ (n; %) | 5 (45.5%) | 2 (20%) | 4 (36.3%) | 7 (50.0%) | 8 (66.7%) |
Females (n; %) | 19 (63.3%) | 14 (58.3%) | 18 (62.1%) | 26 (65%) | 22 (60%) |
CMV− (n; %) | 15 (78.9%) | 8 (57.1%) | 10 (55.6%) | 9 (34.6%) | 7 (31.8%) |
CMV+ (n; %) | 4 (21.1%) | 6 (42.9%) | 8 (44.2%) | 17 (65.4%) | 15 (68.2%) |